Table 2.

Associations of cTnT and NT-proBNP with 30-day readmission or death

	cTnT	NT-proBNP	p for comparison
Acute dyspnea (n = 314)
Unadjusted HR (95% CI)	1.51 (1.26–1.81)	1.17 (1.04–1.32)	0.001
aHR (95% CI)*	1.64 (1.30–2.05)	1.10 (0.94–1.30)	<0.001
AUC (95% CI)	0.66 (0.59–0.72)	0.58 (0.51–0.65)	0.022
Acute HF (n = 143)
Unadjusted HR (95% CI)	1.56 (1.18–2.04)	1.19 (0.94–1.51)	0.023
aHR (95% CI)*	1.58 (1.14–2.18)	1.06 (0.80–1.40)	0.025
AUC (95% CI)	0.66 (0.56–0.75)	0.57 (0.43–0.66)	0.10
HFrEF (n = 91)
Unadjusted HR (95% CI)	1.53 (1.07–2.19)	1.29 (0.94–1.77)	0.28
aHR (95% CI)*	1.52 (0.97–2.38)	1.07 (0.76–1.51)	0.19
AUC (95% CI)	0.66 (0.54–0.77)	0.63 (0.49–0.77)	0.74
HFpEF (n = 52)
Unadjusted HR (95% CI)	1.60 (1.05–2.44)	1.15 (0.78–1.68)	0.13
aHR (95% CI)*	2.04 (1.08–3.87)	1.16 (0.67–2.01)	0.08
AUC (95% CI)	0.67 (0.51–0.83)	0.52 (0.35–0.69)	0.08
Non-HF (n = 171)
Unadjusted HR (95% CI)	1.60 (1.16–2.20)	1.14 (0.94–1.38)	0.038
aHR (95% CI)*	1.74 (1.09–2.79)	1.02 (0.80–1.32)	0.07
AUC (95% CI)	0.64 (0.54–0.73)	0.58 (0.48–0.68)	0.23

AUC, area under the curve; CI, confidence interval; cTnT, cardiac troponin T; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; NT-proBNP, N-terminal pro-B-type natriuretic peptide.

*Adjusted for sex, age, BMI, systolic blood pressure, HF, CAD, AF, eGFR, COPD, and diabetes mellitus.